RxSight Q1 2026 Earnings EPS Miss Weighs on Shares as Revenue Data Unavailable Amphastar Pharmaceuticals AMPH Q1 2026 Earnings EPS Misses Estimates by Over 40 Yet Stock Rises DSGR Q1 2026 Earnings EPS Beat Surprises Market Despite Revenue Discretion IFRX Q4 2025 Earnings NarrowerThanExpected Loss Supports Stock Rally Rush Street Interactive RSI Q1 2026 Earnings Profit Beat Lifts Sentiment Despite Stock Pullback CEPU Q4 2024 Earnings Massive EPS Miss Amid Argentine Macro Headwinds